B7-H3 CAR T cells (B7-H3CART)

B7-H3 CAR T cells · Stanford University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for B7-H3 CAR T cells (B7-H3CART), covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme [Phase 1]